• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Cytomos

To add a bio or update company history, please click update information.

News from Cytomos

    Cytomos secures £5m led by Archangels to scale up production of cell-analysis technologyCytomos secures £5m led by Archangels to scale up production of cell-analysis technology
    Cytomos
    19 Nov 2024

    Cytomos secures £5m led by Archangels to scale up production of cell-analysis technology

    Cytomos builds scalable cell analysis technology that measures intrinsic cellular properties in real time, helping biopharma companies accelerate drug discovery and manufacturing decisions.

Cytomos
  • Life Sciences
  • Edinburgh, United Kingdom
  • £5m
  • cytomos.com
  • Update Information

More venture news

  • Apoha unlocks £27m in funding led by Singular to measure how molecules and materials behave under real-world conditions
    Apoha
    3 Jun 2026

    Apoha unlocks £27m in funding led by Singular to measure how molecules and materials behave under real-world conditions

    EquityLife Sciences
  •  IMU Biosciences unlocks £40m Series A led by IQ Capital and Molten Ventures to decode the immune system with high-resolution blood analysis
    IMU Biosciences
    2 Jun 2026

    IMU Biosciences unlocks £40m Series A led by IQ Capital and Molten Ventures to decode the immune system with high-resolution blood analysis

    Series ALife Sciences
  • Perceptic raises a £9m seed round led by Accel to unify drug discovery and development on a single AI platform
    Perceptic
    28 May 2026

    Perceptic raises a £9m seed round led by Accel to unify drug discovery and development on a single AI platform

    SeedLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn